| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96547e853272614b80b1cabdf8528041 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2021-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a522941fdc1ae8acaf1ddc2ecf0c443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9acc1de2b9c4fb3849a576c82f4796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2a2e85bada9dee07810bfa839f568ae |
| publicationDate |
2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113999913-A |
| titleOfInvention |
Application of biomarkers in predicting sensitivity to tyrosine kinase inhibitors in patients with chronic myeloid leukemia |
| abstract |
The present invention relates to the application of biomarkers in predicting the sensitivity of chronic myeloid leukemia patients to tyrosine kinase inhibitors, the biomarkers include S100A9, VEGFC and/or OSBPL2. The biomarker of the invention has high sensitivity and high specificity, and lays a foundation for customizing a personalized treatment plan for patients with chronic myeloid leukemia. |
| priorityDate |
2021-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |